+634.5%
MRNA vs VSAT
+9.9%
+624.6%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | VSAT | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | +2.5% | -1.8% | +0.4% |
| 7D | -8.2% | +3.4% | -11.7% | -8.8% |
| 30D | +125.6% | -12.2% | +137.8% | +130.2% |
| 3M | +197.1% | +20.6% | +176.4% | +186.1% |
| 6M | +148.5% | +60.2% | +88.3% | +128.2% |
| YTD | +363.3% | +115.3% | +248.0% | +306.5% |
| 1Y | +462.0% | +154.6% | +307.4% | +379.9% |
| 3Y | +26.9% | +211.2% | -184.2% | -4.5% |
| 5Y | -69.6% | +52.7% | -122.3% | -76.8% |
| All | +634.5% | +9.9% | +624.6% | +574.7% |
Cumulative growth
Daily Returns
Daily percentage return beside VSAT.
Daily Out/Under-Performance
Portfolio return minus VSAT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VSAT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded VSAT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling